The University of Southampton
University of Southampton Institutional Repository

A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus

A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus
A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus
Objective: To assess the effectiveness of oral vanadium supplementation for glycaemic control in type 2 diabetes by conducting a systematic review of the literature.
Design and Methods: Eligible studies were identified by searching 14 databases using standardized terms. Experts, study authors and manufacturers were also contacted. Hand-searching was not undertaken. Selection criteria for inclusion in the review were controlled human trials of vanadium vs. placebo in adults with type 2 diabetes of minimum 2 months duration, and a minimum of 10 subjects per arm. Data extraction, assessment of study quality and outcome analysis were undertaken by two independent reviewers.
Results: One hundred and fifty one studies were found but none met the inclusion criteria. We proceeded to summarize the state of existing evidence and plan for a future clinical trial by applying revised, less restrictive criteria to our search, for clinical trials of 30150 mg daily oral vanadium supplementation in diabetic humans. Only five were identified. These demonstrated significant treatment-effects, but due to poor study quality, must be interpreted with caution. Treatment with vanadium often results in gastrointestinal side-effects.
Conclusion: There is no rigorous evidence that oral vanadium supplementation improves glycaemic control in type 2 diabetes. The routine use of vanadium for this purpose cannot be recommended. A large-scale randomized controlled trial is needed to address this clinical question.
risk, databases, diabetes mellitus, insulin sensitivity, adults, sulfate, analysis, time, adult, micronutrients, human, diabetes, review, methods, arm, clinical-trials, placebo, controlled-trial, quality, trial, literature, clinical trials, humans, clinical-trial, treatment, England, design
1460-2725
351-358
Smith, D.M.
88dfac94-ed7d-438d-9581-3dce369e9882
Pickering, R.M.
4a828314-7ddf-4f96-abed-3407017d4c90
Lewith, G.T.
0fc483fa-f17b-47c5-94d9-5c15e65a7625
Smith, D.M.
88dfac94-ed7d-438d-9581-3dce369e9882
Pickering, R.M.
4a828314-7ddf-4f96-abed-3407017d4c90
Lewith, G.T.
0fc483fa-f17b-47c5-94d9-5c15e65a7625

Smith, D.M., Pickering, R.M. and Lewith, G.T. (2008) A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus. QJM: An International Journal of Medicine, 101 (5), 351-358. (doi:10.1093/qjmed/hcn003).

Record type: Article

Abstract

Objective: To assess the effectiveness of oral vanadium supplementation for glycaemic control in type 2 diabetes by conducting a systematic review of the literature.
Design and Methods: Eligible studies were identified by searching 14 databases using standardized terms. Experts, study authors and manufacturers were also contacted. Hand-searching was not undertaken. Selection criteria for inclusion in the review were controlled human trials of vanadium vs. placebo in adults with type 2 diabetes of minimum 2 months duration, and a minimum of 10 subjects per arm. Data extraction, assessment of study quality and outcome analysis were undertaken by two independent reviewers.
Results: One hundred and fifty one studies were found but none met the inclusion criteria. We proceeded to summarize the state of existing evidence and plan for a future clinical trial by applying revised, less restrictive criteria to our search, for clinical trials of 30150 mg daily oral vanadium supplementation in diabetic humans. Only five were identified. These demonstrated significant treatment-effects, but due to poor study quality, must be interpreted with caution. Treatment with vanadium often results in gastrointestinal side-effects.
Conclusion: There is no rigorous evidence that oral vanadium supplementation improves glycaemic control in type 2 diabetes. The routine use of vanadium for this purpose cannot be recommended. A large-scale randomized controlled trial is needed to address this clinical question.

This record has no associated files available for download.

More information

Published date: 2008
Keywords: risk, databases, diabetes mellitus, insulin sensitivity, adults, sulfate, analysis, time, adult, micronutrients, human, diabetes, review, methods, arm, clinical-trials, placebo, controlled-trial, quality, trial, literature, clinical trials, humans, clinical-trial, treatment, England, design

Identifiers

Local EPrints ID: 62134
URI: http://eprints.soton.ac.uk/id/eprint/62134
ISSN: 1460-2725
PURE UUID: 7034dedc-7881-4dab-a15b-2aa11d0028f2

Catalogue record

Date deposited: 10 Sep 2008
Last modified: 15 Mar 2024 11:29

Export record

Altmetrics

Contributors

Author: D.M. Smith
Author: R.M. Pickering
Author: G.T. Lewith

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×